| Document Date: 2014-02-03 14:52:53
Open Document File Size: 234,58 KBShare Result on Facebook
City Reference / / Company Merck Sharp & Dohme Corp. / Merck & Co. Inc. / / Currency pence / / Event FDA Phase / Product Issues / / Facility Mean terminal / Type I complex / / IndustryTerm Treatment of Benign Prostatic Hyperplasia / Therapy of Prostatic Symptoms / chemical name / Prostate Cancer Prevention / food / / MedicalCondition mg Impotence / Neoplasms / hypospadias / adenomas / BPH / Tenderness Rash / Carcinogenesis / erectile dysfunction / chronic / high-grade prostate cancer / sexual dysfunction / libido disorders / male breast cancer / orgasm disorders / ejaculation disorder / pain / urticaria / angioedema / ejaculation disorders / Hypersensitivity / benign prostatic hyperplasia / male infertility / androgenetic alopecia / deficiency / prostate cancer / pruritus / depression / impotence / rash / breast cancer / / MedicalTreatment intravenous infusion / / Organization Intravenous administration / FDA / / / Position rhesus model for human fetal development / investigator / / Product PROPECIA / talc / acetaminophen / estradiol / theophylline / finasteride / digoxin / testosterone / AVODART / PROSCAR / the contact area / / Technology Pharmacokinetics / Pharmacodynamics / anti-infectives / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROPECIA safely and effectively. See full prescribing information